Remove Clinical Development Remove International Remove Protein Production
article thumbnail

Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020

The Pharma Data

International Dial-in Number: (210) 874-7715. Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA. Eloxx’s lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. Time : 4:30 p.m.

article thumbnail

Beyond Steel Tanks

Codon

million liters in 2021, according to an analysis by BioProcess International. market with Wegovy will, by 2030, require about one million liters of production capacity. Once approved, patent-protected drugs are the highest-margin physical products on the planet—even with the high price of bioreactors. Why rock the boat?

article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

Cell-based assays , while more complex to develop and use, offer another option for characterizing product activity at a slightly higher level, allowing sponsors to measure the further downstream effects of products (e.g., morphological cell changes or alterations in protein production or expression).